curexo plasmapp plasma sterilization

South Korea’s GC Biopharma Corp. broke ground on Wednesday on Indonesia’s first blood product plant through technology transfer.Indonesi...

South Korea’s SK Plasma on Tuesday said it signed a term sheet, or a nonbinding agreement on the basic terms and conditions of an investment, ...

South Korea's bioplasma technology firm Plasmapp announced on Friday that it has signed a product supply contract worth 16.4 billion won ($12.3 mill...

South Korea's SK Plasma on Wednesday announced the launch of full-scale production this month of the blood products albumin and immunoglobulin for S...

South Korea's medical robot company Curexo partnered with Kyocera Corporation to enter the Japanese market for artificial joint surgery robots.Curex...

Curexo, a South Korean medical robot company, said on Tuesday that it had unveiled its artificial joint surgery robot "TMAX" at AAOS 2023, the world...

South Korea’s SK Plasma will build a blood products plant in Indonesia.Industry sources on Tuesday said the company recently received approval...

SK Plasma Co. Ltd., a South Korean company specializing in the production of plasma derivatives from human plasma, is expanding its product portfoli...

South Korea's bioplasma technology firm Plasmapp said on Friday that it signed a memorandum of understanding with Curexo, a domestic medical robot m...

SK Discovery Co., an intermediate holding company of South Korea’s third-largest conglomerate SK Group, will take charge of the entire biotech...

South Korea-based biopharmaceutical company TiumBio is set to acquire 30 billion won ($26 million) worth of shares in SK Plasma, a blood product com...